Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
UltraSOL Curcumin is a proprietary, water-dispersible curcumin formulation developed by OmniActive Health Technologies using the UltraSOL Nutrient Delivery System. This technology significantly enhances the bioavailability of curcuminoids—the active polyphenolic compounds extracted from *Curcuma longa* (turmeric)—by converting lipophilic nutrients into a water-dispersible form. Marketed under brand names such as CurcuWIN and CurcuWIN Ultra+, the formulation is designed to overcome the poor absorption typically associated with standard curcumin. It has been clinically studied for its applications in sports nutrition, specifically for reducing exercise-induced muscle damage and improving recovery, as well as for supporting joint health in conditions like osteoarthritis, enhancing endothelial function, and managing systemic inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on UltraSOL Curcumin.